Novel motif:51: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:46, 9 September 2013
name: | motif51_CGGNTA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0097039 | protein linear polyubiquitination | 7.729411e-16 |
GO:0006412 | translation | 6.083579e-14 |
GO:0006348 | chromatin silencing at telomere | 3.311916e-13 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.583428e-13 |
GO:0006449 | regulation of translational termination | 4.921852e-12 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 2.795677e-11 |
GO:0071506 | cellular response to mycophenolic acid | 2.795677e-11 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.924390e-10 |
GO:0000387 | spliceosomal snRNP assembly | 5.161207e-10 |
GO:0072298 | regulation of metanephric glomerulus development | 7.489970e-10 |
GO:0071870 | cellular response to catecholamine stimulus | 8.210512e-10 |
GO:0072110 | glomerular mesangial cell proliferation | 8.270770e-10 |
GO:0045116 | protein neddylation | 2.087799e-9 |
GO:0000183 | chromatin silencing at rDNA | 3.441038e-9 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.257590e-9 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 8.703314e-9 |
GO:0072109 | glomerular mesangium development | 1.866259e-8 |
GO:0010498 | proteasomal protein catabolic process | 2.393005e-8 |
GO:0016032 | viral reproduction | 4.763834e-8 |
GO:0006353 | transcription termination, DNA-dependent | 8.138794e-8 |
GO:0006414 | translational elongation | 9.881145e-8 |
GO:0071504 | cellular response to heparin | 1.656075e-7 |
GO:0007549 | dosage compensation | 1.924965e-7 |
GO:0071569 | protein ufmylation | 2.659952e-7 |
GO:0071874 | cellular response to norepinephrine stimulus | 2.779435e-7 |
GO:0090192 | regulation of glomerulus development | 2.925525e-7 |
GO:0071503 | response to heparin | 4.407361e-7 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 4.466336e-7 |
GO:0006390 | transcription from mitochondrial promoter | 4.510719e-7 |
GO:0051225 | spindle assembly | 4.741479e-7 |
GO:0008612 | peptidyl-lysine modification to hypusine | 5.870865e-7 |
GO:0030327 | prenylated protein catabolic process | 9.028908e-7 |
GO:0043060 | meiotic metaphase I plate congression | 2.022658e-6 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.576293e-6 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.752910e-6 |
GO:0045143 | homologous chromosome segregation | 2.776770e-6 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 3.761879e-6 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 3.972450e-6 |
GO:0000028 | ribosomal small subunit assembly | 4.089032e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.086866e-6 |
GO:0033590 | response to cobalamin | 5.252532e-6 |
GO:0006498 | N-terminal protein lipidation | 5.252532e-6 |
GO:0006117 | acetaldehyde metabolic process | 5.252532e-6 |
GO:0071934 | thiamine transmembrane transport | 5.279137e-6 |
GO:0006415 | translational termination | 5.430161e-6 |
GO:0015812 | gamma-aminobutyric acid transport | 5.451386e-6 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 5.973562e-6 |
GO:0032922 | circadian regulation of gene expression | 6.425969e-6 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 9.888624e-6 |
GO:0051793 | medium-chain fatty acid catabolic process | 9.888624e-6 |
GO:0023035 | CD40 signaling pathway | 9.888624e-6 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.176664e-5 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.336599e-5 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.381621e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.445809e-5 |
GO:0010509 | polyamine homeostasis | 1.445809e-5 |
GO:0030433 | ER-associated protein catabolic process | 1.825704e-5 |
GO:0072111 | cell proliferation involved in kidney development | 2.146363e-5 |
GO:0018277 | protein deamination | 2.359025e-5 |
GO:0042398 | cellular modified amino acid biosynthetic process | 2.370432e-5 |
GO:0009235 | cobalamin metabolic process | 2.386519e-5 |
GO:0034660 | ncRNA metabolic process | 2.424865e-5 |
GO:0051255 | spindle midzone assembly | 3.061098e-5 |
GO:0035461 | vitamin transmembrane transport | 3.219427e-5 |
GO:0015696 | ammonium transport | 3.361696e-5 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.481739e-5 |
GO:0018364 | peptidyl-glutamine methylation | 3.591304e-5 |
GO:0090307 | spindle assembly involved in mitosis | 4.557505e-5 |
GO:0000022 | mitotic spindle elongation | 4.737895e-5 |
GO:0034340 | response to type I interferon | 5.332708e-5 |
GO:0060337 | type I interferon-mediated signaling pathway | 5.834795e-5 |
GO:0042254 | ribosome biogenesis | 5.876657e-5 |
GO:0070293 | renal absorption | 6.364430e-5 |
GO:0040040 | thermosensory behavior | 6.367254e-5 |
GO:0070925 | organelle assembly | 6.978879e-5 |
GO:0019264 | glycine biosynthetic process from serine | 7.423954e-5 |
GO:0061162 | establishment of monopolar cell polarity | 8.071619e-5 |
GO:0072189 | ureter development | 8.071619e-5 |
GO:0035621 | ER to Golgi ceramide transport | 8.104440e-5 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 9.781262e-5 |
GO:0006433 | prolyl-tRNA aminoacylation | 9.784187e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 9.873153e-5 |
GO:0007051 | spindle organization | 9.990104e-5 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.042099e-4 |
GO:0035871 | protein K11-linked deubiquitination | 1.042099e-4 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 1.087742e-4 |
GO:0016578 | histone deubiquitination | 1.200551e-4 |
GO:0035601 | protein deacylation | 1.222923e-4 |
GO:0071398 | cellular response to fatty acid | 1.225039e-4 |
GO:0000959 | mitochondrial RNA metabolic process | 1.225767e-4 |
GO:0006476 | protein deacetylation | 1.268080e-4 |
GO:0019048 | virus-host interaction | 1.271835e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.317979e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 1.343160e-4 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 1.427080e-4 |
GO:0016575 | histone deacetylation | 1.463405e-4 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.474728e-4 |
GO:0050685 | positive regulation of mRNA processing | 1.523681e-4 |
GO:0071480 | cellular response to gamma radiation | 1.523681e-4 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 1.592005e-4 |
GO:0007100 | mitotic centrosome separation | 1.592005e-4 |
GO:0010467 | gene expression | 1.630655e-4 |
GO:0006829 | zinc ion transport | 1.736237e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.901662e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.937173e-4 |
GO:0046015 | regulation of transcription by glucose | 2.093010e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.125327e-4 |
GO:2000597 | positive regulation of optic nerve formation | 2.162884e-4 |
GO:0035799 | ureter maturation | 2.162884e-4 |
GO:0061360 | optic chiasma development | 2.162884e-4 |
GO:0021633 | optic nerve structural organization | 2.162884e-4 |
GO:0021650 | vestibulocochlear nerve formation | 2.162884e-4 |
GO:0009069 | serine family amino acid metabolic process | 2.185809e-4 |
GO:0006369 | termination of RNA polymerase II transcription | 2.214596e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.236761e-4 |
GO:0032042 | mitochondrial DNA metabolic process | 2.330507e-4 |
GO:0071872 | cellular response to epinephrine stimulus | 2.425414e-4 |
GO:0032425 | positive regulation of mismatch repair | 2.470502e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 2.516643e-4 |
GO:0008049 | male courtship behavior | 2.516643e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.537029e-4 |
GO:0071394 | cellular response to testosterone stimulus | 2.591569e-4 |
GO:0006313 | transposition, DNA-mediated | 2.591569e-4 |
GO:0042375 | quinone cofactor metabolic process | 2.734234e-4 |
GO:0045905 | positive regulation of translational termination | 2.742218e-4 |
GO:0045901 | positive regulation of translational elongation | 2.742218e-4 |
GO:0006452 | translational frameshifting | 2.742218e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 2.836078e-4 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 2.887251e-4 |
GO:0051351 | positive regulation of ligase activity | 2.983711e-4 |
GO:0060461 | right lung morphogenesis | 3.227257e-4 |
GO:0090131 | mesenchyme migration | 3.227257e-4 |
GO:0060446 | branching involved in open tracheal system development | 3.227257e-4 |
GO:0048371 | lateral mesodermal cell differentiation | 3.227257e-4 |
GO:0014822 | detection of wounding | 3.227257e-4 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 3.227257e-4 |
GO:0051340 | regulation of ligase activity | 3.389588e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.484901e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 3.684731e-4 |
GO:0006264 | mitochondrial DNA replication | 3.778605e-4 |
GO:0043624 | cellular protein complex disassembly | 3.854437e-4 |
GO:0019083 | viral transcription | 3.909254e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.100817e-4 |
GO:0006363 | termination of RNA polymerase I transcription | 4.137643e-4 |
GO:0051290 | protein heterotetramerization | 4.205003e-4 |
GO:0006516 | glycoprotein catabolic process | 4.352210e-4 |
GO:0006481 | C-terminal protein methylation | 4.364972e-4 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 4.441010e-4 |
GO:0052697 | xenobiotic glucuronidation | 4.441010e-4 |
GO:0070980 | biphenyl catabolic process | 4.441010e-4 |
GO:0052696 | flavonoid glucuronidation | 4.441010e-4 |
GO:0006789 | bilirubin conjugation | 4.441010e-4 |
GO:0051552 | flavone metabolic process | 4.441010e-4 |
GO:0042335 | cuticle development | 4.544485e-4 |
GO:0006479 | protein methylation | 4.569727e-4 |
GO:0022415 | viral reproductive process | 4.625424e-4 |
GO:0060431 | primary lung bud formation | 4.834097e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 4.874501e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.903200e-4 |
GO:0046940 | nucleoside monophosphate phosphorylation | 4.909964e-4 |
GO:0035048 | splicing factor protein import into nucleus | 4.909964e-4 |
GO:0002508 | central tolerance induction | 4.909964e-4 |
GO:0002897 | positive regulation of central B cell tolerance induction | 4.909964e-4 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 5.113240e-4 |
GO:0021603 | cranial nerve formation | 5.262923e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 5.350642e-4 |
GO:0006391 | transcription initiation from mitochondrial promoter | 5.575635e-4 |
GO:0007635 | chemosensory behavior | 5.734829e-4 |
GO:0071423 | malate transmembrane transport | 6.112498e-4 |
GO:0034162 | toll-like receptor 9 signaling pathway | 6.112498e-4 |
GO:0006756 | AMP phosphorylation | 6.112498e-4 |
GO:0015709 | thiosulfate transport | 6.112498e-4 |
GO:0042255 | ribosome assembly | 6.393103e-4 |
GO:0032446 | protein modification by small protein conjugation | 6.477798e-4 |
GO:0043241 | protein complex disassembly | 6.556763e-4 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 6.851527e-4 |
GO:0044342 | type B pancreatic cell proliferation | 6.860984e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 6.860984e-4 |
GO:0016233 | telomere capping | 7.007470e-4 |
GO:0070198 | protein localization to chromosome, telomeric region | 7.301621e-4 |
GO:0051354 | negative regulation of oxidoreductase activity | 7.652129e-4 |
GO:0006420 | arginyl-tRNA aminoacylation | 7.883401e-4 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 7.918303e-4 |
GO:0045090 | retroviral genome replication | 7.918303e-4 |
GO:0051775 | response to redox state | 8.007053e-4 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 8.071577e-4 |
GO:0009589 | detection of UV | 8.071577e-4 |
GO:0000088 | mitotic prophase | 8.071577e-4 |
GO:0048002 | antigen processing and presentation of peptide antigen | 8.453776e-4 |
GO:0055089 | fatty acid homeostasis | 8.526393e-4 |
GO:0000002 | mitochondrial genome maintenance | 8.553018e-4 |
GO:0006458 | 'de novo' protein folding | 8.649778e-4 |
GO:0019941 | modification-dependent protein catabolic process | 8.651883e-4 |
GO:0044265 | cellular macromolecule catabolic process | 8.919016e-4 |
GO:0000723 | telomere maintenance | 9.175448e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 9.499168e-4 |
GO:0021562 | vestibulocochlear nerve development | 9.502203e-4 |
GO:0070634 | transepithelial ammonium transport | 9.762435e-4 |
GO:0006285 | base-excision repair, AP site formation | 9.901074e-4 |
GO:0018342 | protein prenylation | 9.992952e-4 |
GO:0051257 | spindle midzone assembly involved in meiosis | 1.004125e-3 |
GO:0048313 | Golgi inheritance | 1.004125e-3 |
GO:0009804 | coumarin metabolic process | 1.004125e-3 |
GO:0007060 | male meiosis chromosome segregation | 1.004125e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 1.009148e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.082791e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 1.091191e-3 |
GO:0032200 | telomere organization | 1.185900e-3 |
GO:0071109 | superior temporal gyrus development | 1.201218e-3 |
GO:0042373 | vitamin K metabolic process | 1.201218e-3 |
GO:0006499 | N-terminal protein myristoylation | 1.221357e-3 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 1.228164e-3 |
GO:0006914 | autophagy | 1.235996e-3 |
GO:0032581 | ER-dependent peroxisome organization | 1.253010e-3 |
GO:2000252 | negative regulation of feeding behavior | 1.253010e-3 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.253159e-3 |
GO:0006783 | heme biosynthetic process | 1.285692e-3 |
GO:0030262 | apoptotic nuclear change | 1.301531e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 1.316430e-3 |
GO:0015853 | adenine transport | 1.316430e-3 |
GO:0051791 | medium-chain fatty acid metabolic process | 1.362550e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 1.362550e-3 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 1.362550e-3 |
GO:0045190 | isotype switching | 1.368312e-3 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 1.374944e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 1.433985e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.433985e-3 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.483060e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.491457e-3 |
GO:0045792 | negative regulation of cell size | 1.589599e-3 |
GO:0007029 | endoplasmic reticulum organization | 1.663827e-3 |
GO:0048370 | lateral mesoderm formation | 1.677885e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.683309e-3 |
GO:0031860 | telomeric 3' overhang formation | 1.683309e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.692601e-3 |
GO:0060453 | regulation of gastric acid secretion | 1.753436e-3 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.763567e-3 |
GO:0006563 | L-serine metabolic process | 1.763567e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.774639e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.805392e-3 |
GO:0045818 | negative regulation of glycogen catabolic process | 1.813723e-3 |
GO:0006600 | creatine metabolic process | 1.815348e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.868575e-3 |
GO:0009059 | macromolecule biosynthetic process | 1.898545e-3 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.916438e-3 |
GO:0060056 | mammary gland involution | 1.972798e-3 |
GO:0002003 | angiotensin maturation | 1.976590e-3 |
GO:0016072 | rRNA metabolic process | 2.064451e-3 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 2.167918e-3 |
GO:0032774 | RNA biosynthetic process | 2.219491e-3 |
GO:0014038 | regulation of Schwann cell differentiation | 2.242892e-3 |
GO:0045065 | cytotoxic T cell differentiation | 2.301549e-3 |
GO:0045163 | clustering of voltage-gated potassium channels | 2.328757e-3 |
GO:0019086 | late viral mRNA transcription | 2.384634e-3 |
GO:0003406 | retinal pigment epithelium development | 2.384634e-3 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 2.390168e-3 |
GO:0033013 | tetrapyrrole metabolic process | 2.490067e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.550117e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 2.603863e-3 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.603863e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 2.606632e-3 |
GO:0010966 | regulation of phosphate transport | 2.656657e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.656657e-3 |
GO:0048676 | axon extension involved in development | 2.688442e-3 |
GO:0018293 | protein-FAD linkage | 2.701682e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 2.701682e-3 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 2.701682e-3 |
GO:0000076 | DNA replication checkpoint | 2.721718e-3 |
GO:0006534 | cysteine metabolic process | 2.732089e-3 |
GO:0072176 | nephric duct development | 2.791110e-3 |
GO:0046080 | dUTP metabolic process | 2.812929e-3 |
GO:0006268 | DNA unwinding involved in replication | 2.842167e-3 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 2.862937e-3 |
GO:0010506 | regulation of autophagy | 2.873704e-3 |
GO:0003096 | renal sodium ion transport | 2.965866e-3 |
GO:0033119 | negative regulation of RNA splicing | 2.966975e-3 |
GO:0006778 | porphyrin-containing compound metabolic process | 3.004272e-3 |
GO:0035566 | regulation of metanephros size | 3.020304e-3 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 3.097539e-3 |
GO:0006413 | translational initiation | 3.163825e-3 |
GO:0006824 | cobalt ion transport | 3.259435e-3 |
GO:0070857 | regulation of bile acid biosynthetic process | 3.282350e-3 |
GO:0016598 | protein arginylation | 3.285866e-3 |
GO:0070682 | proteasome regulatory particle assembly | 3.285866e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 3.285866e-3 |
GO:0048790 | maintenance of presynaptic active zone structure | 3.357169e-3 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 3.357169e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.392509e-3 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 3.511375e-3 |
GO:0007340 | acrosome reaction | 3.513549e-3 |
GO:0021557 | oculomotor nerve development | 3.529070e-3 |
GO:0006446 | regulation of translational initiation | 3.540715e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 3.582166e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 3.589809e-3 |
GO:0071105 | response to interleukin-11 | 3.592168e-3 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 3.592168e-3 |
GO:0048855 | adenohypophysis morphogenesis | 3.592168e-3 |
GO:0060574 | intestinal epithelial cell maturation | 3.602079e-3 |
GO:0045426 | quinone cofactor biosynthetic process | 3.630083e-3 |
GO:0006544 | glycine metabolic process | 3.677448e-3 |
GO:0072132 | mesenchyme morphogenesis | 3.781084e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 3.783915e-3 |
GO:0060286 | flagellar cell motility | 3.816948e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 3.816948e-3 |
GO:0010933 | positive regulation of macrophage tolerance induction | 3.816948e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 3.964949e-3 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 3.971508e-3 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 3.980895e-3 |
GO:0006564 | L-serine biosynthetic process | 3.987521e-3 |
GO:0090193 | positive regulation of glomerulus development | 4.000336e-3 |
GO:0006750 | glutathione biosynthetic process | 4.083486e-3 |
GO:0006998 | nuclear envelope organization | 4.128028e-3 |
GO:0006545 | glycine biosynthetic process | 4.228615e-3 |
GO:0018065 | protein-cofactor linkage | 4.237530e-3 |
GO:0060179 | male mating behavior | 4.284579e-3 |
GO:0033205 | cell cycle cytokinesis | 4.342698e-3 |
GO:0046033 | AMP metabolic process | 4.422686e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 4.437849e-3 |
GO:0006182 | cGMP biosynthetic process | 4.467979e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 4.588024e-3 |
GO:0046601 | positive regulation of centriole replication | 4.588024e-3 |
GO:0043308 | eosinophil degranulation | 4.588024e-3 |
GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 4.588024e-3 |
GO:0010388 | cullin deneddylation | 4.625940e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 4.630407e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 4.692482e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 4.711817e-3 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 4.718029e-3 |
GO:0035635 | entry of bacterium into host cell | 4.718029e-3 |
GO:0016266 | O-glycan processing | 4.718029e-3 |
GO:0010722 | regulation of ferrochelatase activity | 4.718029e-3 |
GO:0015866 | ADP transport | 4.782287e-3 |
GO:0060003 | copper ion export | 4.782287e-3 |
GO:0015677 | copper ion import | 4.782287e-3 |
GO:0070294 | renal sodium ion absorption | 4.826249e-3 |
GO:0046785 | microtubule polymerization | 4.826249e-3 |
GO:0072178 | nephric duct morphogenesis | 4.828289e-3 |
GO:0044068 | modulation by symbiont of host cellular process | 4.828289e-3 |
GO:0015840 | urea transport | 4.881507e-3 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.921790e-3 |
GO:0002635 | negative regulation of germinal center formation | 4.959086e-3 |
GO:0006901 | vesicle coating | 5.011166e-3 |
GO:0016567 | protein ubiquitination | 5.231300e-3 |
GO:0090304 | nucleic acid metabolic process | 5.238746e-3 |
GO:0010823 | negative regulation of mitochondrion organization | 5.355237e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 5.400030e-3 |
GO:0006406 | mRNA export from nucleus | 5.402158e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 5.454017e-3 |
GO:0034623 | cellular macromolecular complex disassembly | 5.587283e-3 |
GO:0006405 | RNA export from nucleus | 5.589004e-3 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 5.597064e-3 |
GO:0019344 | cysteine biosynthetic process | 5.763868e-3 |
GO:0051256 | spindle midzone assembly involved in mitosis | 5.763868e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 5.851214e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 5.870212e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 5.966798e-3 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 5.966798e-3 |
GO:0070295 | renal water absorption | 5.980112e-3 |
GO:0042168 | heme metabolic process | 5.987663e-3 |
GO:0043248 | proteasome assembly | 6.367098e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 6.541531e-3 |
GO:0061015 | snRNA import into nucleus | 6.573086e-3 |
GO:0006393 | termination of mitochondrial transcription | 6.573086e-3 |
GO:0090083 | regulation of inclusion body assembly | 6.577257e-3 |
GO:0045908 | negative regulation of vasodilation | 6.606077e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 6.719475e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 6.719475e-3 |
GO:0071281 | cellular response to iron ion | 6.868765e-3 |
GO:0061009 | common bile duct development | 6.868765e-3 |
GO:0033133 | positive regulation of glucokinase activity | 6.916151e-3 |
GO:0090085 | regulation of protein deubiquitination | 7.016653e-3 |
GO:0006598 | polyamine catabolic process | 7.016653e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 7.135847e-3 |
GO:0070633 | transepithelial transport | 7.206208e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 7.242368e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 7.282689e-3 |
GO:0007021 | tubulin complex assembly | 7.306739e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 7.679481e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 7.722417e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 7.860033e-3 |
GO:0032984 | macromolecular complex disassembly | 7.871394e-3 |
GO:0006364 | rRNA processing | 8.108996e-3 |
GO:0045454 | cell redox homeostasis | 8.217061e-3 |
GO:0010821 | regulation of mitochondrion organization | 8.226206e-3 |
GO:0072177 | mesonephric duct development | 8.266219e-3 |
GO:0000236 | mitotic prometaphase | 8.268451e-3 |
GO:0060049 | regulation of protein glycosylation | 8.290550e-3 |
GO:0016070 | RNA metabolic process | 8.341620e-3 |
GO:0044257 | cellular protein catabolic process | 8.369697e-3 |
GO:0006749 | glutathione metabolic process | 8.372892e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 8.385462e-3 |
GO:0033238 | regulation of cellular amine metabolic process | 8.465267e-3 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 8.469986e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 8.565174e-3 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 8.723723e-3 |
GO:0046690 | response to tellurium ion | 8.844453e-3 |
GO:0031627 | telomeric loop formation | 8.844453e-3 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 8.844453e-3 |
GO:0009645 | response to low light intensity stimulus | 8.844453e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 8.899152e-3 |
GO:0051320 | S phase | 8.984748e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 8.994547e-3 |
GO:0016925 | protein sumoylation | 9.143650e-3 |
GO:0006744 | ubiquinone biosynthetic process | 9.551968e-3 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 9.671790e-3 |
GO:0045204 | MAPK export from nucleus | 9.671790e-3 |
GO:0071415 | cellular response to purine-containing compound | 9.675704e-3 |
GO:0060356 | leucine import | 9.675704e-3 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 9.701949e-3 |
GO:0071347 | cellular response to interleukin-1 | 9.743854e-3 |
GO:0019230 | proprioception | 1.014342e-2 |
GO:0016344 | meiotic chromosome movement towards spindle pole | 1.014342e-2 |
GO:0030513 | positive regulation of BMP signaling pathway | 1.022433e-2 |
GO:0060285 | ciliary cell motility | 1.037593e-2 |
GO:0045836 | positive regulation of meiosis | 1.043957e-2 |
GO:0072012 | glomerulus vasculature development | 1.047815e-2 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 1.054944e-2 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 1.054944e-2 |
GO:0006144 | purine base metabolic process | 1.057583e-2 |
GO:0042472 | inner ear morphogenesis | 1.080401e-2 |
GO:0035646 | endosome to melanosome transport | 1.082915e-2 |
GO:0070846 | Hsp90 deacetylation | 1.082915e-2 |
GO:0090042 | tubulin deacetylation | 1.082915e-2 |
GO:0046168 | glycerol-3-phosphate catabolic process | 1.082915e-2 |
GO:0034470 | ncRNA processing | 1.086496e-2 |
GO:0043585 | nose morphogenesis | 1.093864e-2 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.099627e-2 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.105261e-2 |
GO:0042491 | auditory receptor cell differentiation | 1.108619e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.126502e-2 |
GO:0060900 | embryonic camera-type eye formation | 1.143974e-2 |
GO:0072215 | regulation of metanephros development | 1.154232e-2 |
GO:0070317 | negative regulation of G0 to G1 transition | 1.159052e-2 |
GO:0007072 | positive regulation of transcription on exit from mitosis | 1.159052e-2 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.160925e-2 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.185382e-2 |
GO:0006351 | transcription, DNA-dependent | 1.187444e-2 |
GO:0007158 | neuron cell-cell adhesion | 1.192913e-2 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 1.197335e-2 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.197335e-2 |
GO:0071542 | dopaminergic neuron differentiation | 1.202458e-2 |
GO:0060988 | lipid tube assembly | 1.205673e-2 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.205673e-2 |
GO:0043486 | histone exchange | 1.209512e-2 |
GO:0019478 | D-amino acid catabolic process | 1.221395e-2 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.221395e-2 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 1.222518e-2 |
GO:0040009 | regulation of growth rate | 1.222518e-2 |
GO:0046607 | positive regulation of centrosome cycle | 1.255364e-2 |
GO:0009386 | translational attenuation | 1.255364e-2 |
GO:0030644 | cellular chloride ion homeostasis | 1.256166e-2 |
GO:0006685 | sphingomyelin catabolic process | 1.256166e-2 |
GO:0032205 | negative regulation of telomere maintenance | 1.279361e-2 |
GO:0072171 | mesonephric tubule morphogenesis | 1.301349e-2 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 1.318383e-2 |
GO:0055081 | anion homeostasis | 1.334304e-2 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.335573e-2 |
GO:0006177 | GMP biosynthetic process | 1.356878e-2 |
GO:0071526 | semaphorin-plexin signaling pathway | 1.390546e-2 |
GO:0045007 | depurination | 1.396967e-2 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.397878e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.422976e-2 |
GO:0032210 | regulation of telomere maintenance via telomerase | 1.428344e-2 |
GO:2000272 | negative regulation of receptor activity | 1.454333e-2 |
GO:0072202 | cell differentiation involved in metanephros development | 1.454333e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.464093e-2 |
GO:0060480 | lung goblet cell differentiation | 1.464771e-2 |
GO:0045964 | positive regulation of dopamine metabolic process | 1.464771e-2 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.464771e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.470439e-2 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.481232e-2 |
GO:0005978 | glycogen biosynthetic process | 1.482962e-2 |
GO:0060253 | negative regulation of glial cell proliferation | 1.495311e-2 |
GO:0000209 | protein polyubiquitination | 1.507607e-2 |
GO:0071407 | cellular response to organic cyclic compound | 1.542254e-2 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.547502e-2 |
GO:0060745 | mammary gland branching involved in pregnancy | 1.563757e-2 |
GO:0000422 | mitochondrion degradation | 1.574553e-2 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.581686e-2 |
GO:0007501 | mesodermal cell fate specification | 1.581686e-2 |
GO:0015680 | intracellular copper ion transport | 1.588816e-2 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.596831e-2 |
GO:0042135 | neurotransmitter catabolic process | 1.613428e-2 |
GO:0021794 | thalamus development | 1.642008e-2 |
GO:0090168 | Golgi reassembly | 1.652602e-2 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 1.652602e-2 |
GO:0031064 | negative regulation of histone deacetylation | 1.658962e-2 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 1.668220e-2 |
GO:0006396 | RNA processing | 1.681734e-2 |
GO:0046416 | D-amino acid metabolic process | 1.737817e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.737817e-2 |
GO:0042443 | phenylethylamine metabolic process | 1.737817e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.737817e-2 |
GO:0034259 | negative regulation of Rho GTPase activity | 1.740306e-2 |
GO:0051567 | histone H3-K9 methylation | 1.761077e-2 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 1.761077e-2 |
GO:0019087 | transformation of host cell by virus | 1.765488e-2 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.766140e-2 |
GO:0045008 | depyrimidination | 1.817361e-2 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.817361e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0044260 | cellular macromolecule metabolic process | 8.234592e-13 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.226498e-10 |
GO:0009452 | RNA capping | 9.204365e-10 |
GO:0009059 | macromolecule biosynthetic process | 1.985019e-9 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 6.240895e-9 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 6.240895e-9 |
GO:0051168 | nuclear export | 1.455673e-8 |
GO:0060318 | definitive erythrocyte differentiation | 1.472982e-8 |
GO:0006603 | phosphocreatine metabolic process | 1.750564e-8 |
GO:0090185 | negative regulation of kidney development | 7.379670e-8 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 1.013431e-7 |
GO:0048389 | intermediate mesoderm development | 1.013431e-7 |
GO:0044249 | cellular biosynthetic process | 2.211044e-7 |
GO:0043966 | histone H3 acetylation | 2.298301e-7 |
GO:0090304 | nucleic acid metabolic process | 2.471486e-7 |
GO:0044237 | cellular metabolic process | 2.498716e-7 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.793521e-7 |
GO:0006505 | GPI anchor metabolic process | 3.000800e-7 |
GO:0006013 | mannose metabolic process | 3.678158e-7 |
GO:0010467 | gene expression | 3.767192e-7 |
GO:0044267 | cellular protein metabolic process | 3.951659e-7 |
GO:0045792 | negative regulation of cell size | 3.968901e-7 |
GO:0006475 | internal protein amino acid acetylation | 7.145112e-7 |
GO:0045066 | regulatory T cell differentiation | 1.354929e-6 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.692107e-6 |
GO:0042254 | ribosome biogenesis | 1.715224e-6 |
GO:0007183 | SMAD protein complex assembly | 1.732064e-6 |
GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.754854e-6 |
GO:0046907 | intracellular transport | 1.779414e-6 |
GO:0006370 | mRNA capping | 1.822839e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.897693e-6 |
GO:0018394 | peptidyl-lysine acetylation | 2.137997e-6 |
GO:0016573 | histone acetylation | 2.466455e-6 |
GO:0006325 | chromatin organization | 2.976399e-6 |
GO:0006473 | protein acetylation | 3.024297e-6 |
GO:0044262 | cellular carbohydrate metabolic process | 3.455500e-6 |
GO:0035674 | tricarboxylic acid transmembrane transport | 3.577805e-6 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 3.629489e-6 |
GO:0072190 | ureter urothelium development | 3.958128e-6 |
GO:0009058 | biosynthetic process | 4.177542e-6 |
GO:0006302 | double-strand break repair | 4.442181e-6 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 4.993115e-6 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 5.459630e-6 |
GO:0006661 | phosphatidylinositol biosynthetic process | 5.801133e-6 |
GO:0006506 | GPI anchor biosynthetic process | 6.474093e-6 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6.536981e-6 |
GO:0006275 | regulation of DNA replication | 6.704684e-6 |
GO:0060433 | bronchus development | 8.525151e-6 |
GO:0016070 | RNA metabolic process | 8.623999e-6 |
GO:0016568 | chromatin modification | 9.016395e-6 |
GO:0043163 | cell envelope organization | 9.093007e-6 |
GO:0032218 | riboflavin transport | 9.093007e-6 |
GO:0006807 | nitrogen compound metabolic process | 9.404855e-6 |
GO:0060299 | negative regulation of sarcomere organization | 1.041911e-5 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.041911e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.090354e-5 |
GO:0032774 | RNA biosynthetic process | 1.097796e-5 |
GO:0051169 | nuclear transport | 1.143596e-5 |
GO:0090086 | negative regulation of protein deubiquitination | 1.173242e-5 |
GO:0006351 | transcription, DNA-dependent | 1.271313e-5 |
GO:0006044 | N-acetylglucosamine metabolic process | 1.416804e-5 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.590934e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 1.692142e-5 |
GO:0010765 | positive regulation of sodium ion transport | 1.833517e-5 |
GO:0031536 | positive regulation of exit from mitosis | 2.058186e-5 |
GO:0000492 | box C/D snoRNP assembly | 2.228448e-5 |
GO:0043543 | protein acylation | 2.271193e-5 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 2.379685e-5 |
GO:0090083 | regulation of inclusion body assembly | 2.439863e-5 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.447956e-5 |
GO:0018193 | peptidyl-amino acid modification | 2.457259e-5 |
GO:0006913 | nucleocytoplasmic transport | 3.048086e-5 |
GO:0018205 | peptidyl-lysine modification | 3.187982e-5 |
GO:0060712 | spongiotrophoblast layer development | 3.369771e-5 |
GO:0051276 | chromosome organization | 3.384291e-5 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 3.411717e-5 |
GO:0043170 | macromolecule metabolic process | 3.727254e-5 |
GO:0035269 | protein O-linked mannosylation | 3.886670e-5 |
GO:0050775 | positive regulation of dendrite morphogenesis | 4.201023e-5 |
GO:0035993 | deltoid tuberosity development | 4.366268e-5 |
GO:0043623 | cellular protein complex assembly | 4.429578e-5 |
GO:0030262 | apoptotic nuclear change | 4.440552e-5 |
GO:0070925 | organelle assembly | 4.685461e-5 |
GO:0072239 | metanephric glomerulus vasculature development | 4.826609e-5 |
GO:0009992 | cellular water homeostasis | 4.959571e-5 |
GO:0072012 | glomerulus vasculature development | 4.983392e-5 |
GO:0071470 | cellular response to osmotic stress | 5.081650e-5 |
GO:0019348 | dolichol metabolic process | 5.219651e-5 |
GO:0060255 | regulation of macromolecule metabolic process | 5.585012e-5 |
GO:0043407 | negative regulation of MAP kinase activity | 5.728209e-5 |
GO:0051932 | synaptic transmission, GABAergic | 5.738201e-5 |
GO:0006405 | RNA export from nucleus | 5.738735e-5 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 5.745138e-5 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 6.460423e-5 |
GO:0072208 | metanephric smooth muscle tissue development | 6.696903e-5 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 6.696903e-5 |
GO:0072259 | metanephric interstitial cell development | 6.696903e-5 |
GO:0072168 | specification of anterior mesonephric tubule identity | 6.696903e-5 |
GO:0072169 | specification of posterior mesonephric tubule identity | 6.696903e-5 |
GO:0072184 | renal vesicle progenitor cell differentiation | 6.696903e-5 |
GO:0005996 | monosaccharide metabolic process | 7.140185e-5 |
GO:0006886 | intracellular protein transport | 7.318055e-5 |
GO:0051403 | stress-activated MAPK cascade | 7.373932e-5 |
GO:0035315 | hair cell differentiation | 7.469798e-5 |
GO:0006391 | transcription initiation from mitochondrial promoter | 7.469798e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.549005e-5 |
GO:0032383 | regulation of intracellular cholesterol transport | 9.021702e-5 |
GO:2000781 | positive regulation of double-strand break repair | 9.021702e-5 |
GO:0016051 | carbohydrate biosynthetic process | 9.255040e-5 |
GO:0002098 | tRNA wobble uridine modification | 9.290441e-5 |
GO:0006364 | rRNA processing | 1.007629e-4 |
GO:0035990 | tendon cell differentiation | 1.030565e-4 |
GO:0051302 | regulation of cell division | 1.052696e-4 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 1.103081e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 1.159687e-4 |
GO:0043587 | tongue morphogenesis | 1.178274e-4 |
GO:0006972 | hyperosmotic response | 1.238922e-4 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.239978e-4 |
GO:0051881 | regulation of mitochondrial membrane potential | 1.253262e-4 |
GO:0006611 | protein export from nucleus | 1.279474e-4 |
GO:0015746 | citrate transport | 1.294990e-4 |
GO:0072143 | mesangial cell development | 1.297374e-4 |
GO:0000725 | recombinational repair | 1.404717e-4 |
GO:0016072 | rRNA metabolic process | 1.462413e-4 |
GO:0090218 | positive regulation of lipid kinase activity | 1.512818e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 1.586428e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.586428e-4 |
GO:0046039 | GTP metabolic process | 1.698499e-4 |
GO:0043586 | tongue development | 1.817729e-4 |
GO:0006406 | mRNA export from nucleus | 1.845164e-4 |
GO:0017148 | negative regulation of translation | 1.877249e-4 |
GO:0031584 | activation of phospholipase D activity | 1.983805e-4 |
GO:0060272 | embryonic skeletal joint morphogenesis | 2.034577e-4 |
GO:0018202 | peptidyl-histidine modification | 2.048909e-4 |
GO:0006921 | cellular component disassembly involved in apoptosis | 2.120647e-4 |
GO:0009889 | regulation of biosynthetic process | 2.124039e-4 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 2.128880e-4 |
GO:0060711 | labyrinthine layer development | 2.184904e-4 |
GO:0045992 | negative regulation of embryonic development | 2.232135e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 2.232135e-4 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 2.232135e-4 |
GO:0010468 | regulation of gene expression | 2.261414e-4 |
GO:0071474 | cellular hyperosmotic response | 2.367209e-4 |
GO:0042048 | olfactory behavior | 2.367209e-4 |
GO:0033013 | tetrapyrrole metabolic process | 2.488253e-4 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.508843e-4 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.526696e-4 |
GO:0000917 | barrier septum formation | 2.526696e-4 |
GO:0045581 | negative regulation of T cell differentiation | 2.628829e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 2.655262e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.669376e-4 |
GO:0006184 | GTP catabolic process | 2.673949e-4 |
GO:0010544 | negative regulation of platelet activation | 2.779230e-4 |
GO:0060235 | lens induction in camera-type eye | 2.890213e-4 |
GO:0021871 | forebrain regionalization | 3.123784e-4 |
GO:0072498 | embryonic skeletal joint development | 3.190383e-4 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 3.347029e-4 |
GO:0072192 | ureter epithelial cell differentiation | 3.347029e-4 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 3.347029e-4 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 3.347029e-4 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 3.347029e-4 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 3.347029e-4 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 3.347029e-4 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 3.347029e-4 |
GO:0090194 | negative regulation of glomerulus development | 3.347029e-4 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 3.347029e-4 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 3.347029e-4 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 3.347029e-4 |
GO:0048392 | intermediate mesodermal cell differentiation | 3.347029e-4 |
GO:0007500 | mesodermal cell fate determination | 3.347029e-4 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 3.347029e-4 |
GO:0060503 | bud dilation involved in lung branching | 3.347029e-4 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 3.347029e-4 |
GO:0071422 | succinate transmembrane transport | 3.347029e-4 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 3.347029e-4 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 3.347029e-4 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 3.347029e-4 |
GO:0034622 | cellular macromolecular complex assembly | 3.361275e-4 |
GO:0031128 | developmental induction | 3.379996e-4 |
GO:0031323 | regulation of cellular metabolic process | 3.481391e-4 |
GO:0042696 | menarche | 3.521753e-4 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 3.521753e-4 |
GO:0019673 | GDP-mannose metabolic process | 3.521753e-4 |
GO:0006071 | glycerol metabolic process | 3.585781e-4 |
GO:0051781 | positive regulation of cell division | 3.642895e-4 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 3.817721e-4 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 4.254071e-4 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 4.378456e-4 |
GO:0072361 | regulation of glycolysis by regulation of transcription from RNA polymerase II promoter | 4.378456e-4 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 4.437846e-4 |
GO:0032922 | circadian regulation of gene expression | 4.546778e-4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 4.550973e-4 |
GO:0019318 | hexose metabolic process | 4.702124e-4 |
GO:0010994 | free ubiquitin chain polymerization | 5.065840e-4 |
GO:0006270 | DNA-dependent DNA replication initiation | 5.241638e-4 |
GO:0006996 | organelle organization | 5.247009e-4 |
GO:0006778 | porphyrin-containing compound metabolic process | 5.520882e-4 |
GO:0048268 | clathrin coat assembly | 5.593552e-4 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 5.650505e-4 |
GO:0045740 | positive regulation of DNA replication | 5.666199e-4 |
GO:0090085 | regulation of protein deubiquitination | 5.694308e-4 |
GO:0034227 | tRNA thio-modification | 5.694308e-4 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 5.694308e-4 |
GO:0000271 | polysaccharide biosynthetic process | 5.909763e-4 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 5.913531e-4 |
GO:0045843 | negative regulation of striated muscle tissue development | 5.925382e-4 |
GO:0021759 | globus pallidus development | 5.943451e-4 |
GO:0006298 | mismatch repair | 5.980931e-4 |
GO:0006412 | translation | 6.086639e-4 |
GO:0032728 | positive regulation of interferon-beta production | 6.395354e-4 |
GO:0006901 | vesicle coating | 6.395354e-4 |
GO:0048488 | synaptic vesicle endocytosis | 6.481943e-4 |
GO:0035356 | cellular triglyceride homeostasis | 6.593875e-4 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 6.593875e-4 |
GO:0006348 | chromatin silencing at telomere | 6.593875e-4 |
GO:0018106 | peptidyl-histidine phosphorylation | 6.656290e-4 |
GO:0000710 | meiotic mismatch repair | 6.656290e-4 |
GO:0018364 | peptidyl-glutamine methylation | 7.045539e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 7.045539e-4 |
GO:0018198 | peptidyl-cysteine modification | 7.359909e-4 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 7.448962e-4 |
GO:0007525 | somatic muscle development | 7.448962e-4 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 7.452398e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.504072e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 7.592109e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 8.313481e-4 |
GO:0006464 | protein modification process | 8.347242e-4 |
GO:0006281 | DNA repair | 8.449678e-4 |
GO:0032769 | negative regulation of monooxygenase activity | 8.548722e-4 |
GO:0072111 | cell proliferation involved in kidney development | 8.699773e-4 |
GO:0072104 | glomerular capillary formation | 8.771900e-4 |
GO:0006599 | phosphagen metabolic process | 8.887146e-4 |
GO:0060438 | trachea development | 9.368499e-4 |
GO:0045017 | glycerolipid biosynthetic process | 9.474913e-4 |
GO:0032910 | regulation of transforming growth factor beta3 production | 9.850762e-4 |
GO:0051054 | positive regulation of DNA metabolic process | 1.022973e-3 |
GO:0007096 | regulation of exit from mitosis | 1.029384e-3 |
GO:0060439 | trachea morphogenesis | 1.029495e-3 |
GO:0006417 | regulation of translation | 1.067751e-3 |
GO:0046314 | phosphocreatine biosynthetic process | 1.087924e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.087924e-3 |
GO:0006538 | glutamate catabolic process | 1.103439e-3 |
GO:0072224 | metanephric glomerulus development | 1.142059e-3 |
GO:0070233 | negative regulation of T cell apoptosis | 1.153020e-3 |
GO:0072109 | glomerular mesangium development | 1.190425e-3 |
GO:0006108 | malate metabolic process | 1.190425e-3 |
GO:0050999 | regulation of nitric-oxide synthase activity | 1.255186e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.255306e-3 |
GO:0035166 | post-embryonic hemopoiesis | 1.255306e-3 |
GO:0006457 | protein folding | 1.312310e-3 |
GO:0019400 | alditol metabolic process | 1.340119e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.353917e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 1.381396e-3 |
GO:0051052 | regulation of DNA metabolic process | 1.410375e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 1.435802e-3 |
GO:0048635 | negative regulation of muscle organ development | 1.463101e-3 |
GO:0032682 | negative regulation of chemokine production | 1.465755e-3 |
GO:0030070 | insulin processing | 1.465755e-3 |
GO:0035621 | ER to Golgi ceramide transport | 1.472436e-3 |
GO:0045136 | development of secondary sexual characteristics | 1.481789e-3 |
GO:0006497 | protein lipidation | 1.489890e-3 |
GO:0042770 | signal transduction in response to DNA damage | 1.516630e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.593980e-3 |
GO:0031468 | nuclear envelope reassembly | 1.618604e-3 |
GO:0007051 | spindle organization | 1.621977e-3 |
GO:0071243 | cellular response to arsenic-containing substance | 1.632465e-3 |
GO:0006310 | DNA recombination | 1.666260e-3 |
GO:0042552 | myelination | 1.689438e-3 |
GO:0010458 | exit from mitosis | 1.695180e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.698879e-3 |
GO:0043412 | macromolecule modification | 1.713504e-3 |
GO:0016578 | histone deubiquitination | 1.723042e-3 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.741693e-3 |
GO:0033522 | histone H2A ubiquitination | 1.750244e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 1.819432e-3 |
GO:0006040 | amino sugar metabolic process | 1.833983e-3 |
GO:0045116 | protein neddylation | 1.835568e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 1.835568e-3 |
GO:0001835 | blastocyst hatching | 1.835568e-3 |
GO:0030166 | proteoglycan biosynthetic process | 1.847182e-3 |
GO:0006605 | protein targeting | 1.878317e-3 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 1.885499e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.904305e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.989404e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.990366e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 2.002139e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 2.002139e-3 |
GO:0070244 | negative regulation of thymocyte apoptosis | 2.009195e-3 |
GO:0070316 | regulation of G0 to G1 transition | 2.080873e-3 |
GO:0021536 | diencephalon development | 2.166769e-3 |
GO:0035887 | aortic smooth muscle cell differentiation | 2.240629e-3 |
GO:0002268 | follicular dendritic cell differentiation | 2.240629e-3 |
GO:0007088 | regulation of mitosis | 2.263987e-3 |
GO:0010821 | regulation of mitochondrion organization | 2.265461e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.343698e-3 |
GO:0022417 | protein maturation by protein folding | 2.343698e-3 |
GO:0006006 | glucose metabolic process | 2.355721e-3 |
GO:0045620 | negative regulation of lymphocyte differentiation | 2.361491e-3 |
GO:0019432 | triglyceride biosynthetic process | 2.402423e-3 |
GO:0033673 | negative regulation of kinase activity | 2.488827e-3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.646778e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 2.646778e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 2.646778e-3 |
GO:0046591 | embryonic leg joint morphogenesis | 2.656661e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 2.656661e-3 |
GO:0034111 | negative regulation of homotypic cell-cell adhesion | 2.714466e-3 |
GO:0016574 | histone ubiquitination | 2.729516e-3 |
GO:0034101 | erythrocyte homeostasis | 2.732067e-3 |
GO:0005975 | carbohydrate metabolic process | 2.781635e-3 |
GO:0014826 | vein smooth muscle contraction | 2.798017e-3 |
GO:0034613 | cellular protein localization | 2.849432e-3 |
GO:0060674 | placenta blood vessel development | 2.934126e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 3.013994e-3 |
GO:0019858 | cytosine metabolic process | 3.013994e-3 |
GO:0008049 | male courtship behavior | 3.013994e-3 |
GO:0002462 | tolerance induction to nonself antigen | 3.013994e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 3.103858e-3 |
GO:0000724 | double-strand break repair via homologous recombination | 3.202364e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 3.211961e-3 |
GO:0043312 | neutrophil degranulation | 3.211961e-3 |
GO:0009057 | macromolecule catabolic process | 3.212327e-3 |
GO:0000279 | M phase | 3.219823e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 3.221178e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 3.247010e-3 |
GO:0060440 | trachea formation | 3.247010e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 3.294944e-3 |
GO:0000183 | chromatin silencing at rDNA | 3.296191e-3 |
GO:0060449 | bud elongation involved in lung branching | 3.309359e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 3.317427e-3 |
GO:0016458 | gene silencing | 3.322663e-3 |
GO:0002513 | tolerance induction to self antigen | 3.349622e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 3.362354e-3 |
GO:0008366 | axon ensheathment | 3.407438e-3 |
GO:0080090 | regulation of primary metabolic process | 3.425971e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 3.458786e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 3.524435e-3 |
GO:0070727 | cellular macromolecule localization | 3.527817e-3 |
GO:0006756 | AMP phosphorylation | 3.536874e-3 |
GO:0009261 | ribonucleotide catabolic process | 3.567039e-3 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 3.604936e-3 |
GO:0072215 | regulation of metanephros development | 3.610244e-3 |
GO:0046504 | glycerol ether biosynthetic process | 3.621119e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 3.629629e-3 |
GO:0017038 | protein import | 3.645416e-3 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 3.773446e-3 |
GO:0060428 | lung epithelium development | 3.843011e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 3.900842e-3 |
GO:0010388 | cullin deneddylation | 3.900842e-3 |
GO:0006974 | response to DNA damage stimulus | 3.905468e-3 |
GO:0060216 | definitive hemopoiesis | 4.000954e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 4.047284e-3 |
GO:0030433 | ER-associated protein catabolic process | 4.049334e-3 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 4.099852e-3 |
GO:0006536 | glutamate metabolic process | 4.116197e-3 |
GO:0002089 | lens morphogenesis in camera-type eye | 4.311403e-3 |
GO:0008380 | RNA splicing | 4.338048e-3 |
GO:0006260 | DNA replication | 4.393926e-3 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 4.447266e-3 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 4.447266e-3 |
GO:0006287 | base-excision repair, gap-filling | 4.531861e-3 |
GO:0001302 | replicative cell aging | 4.555700e-3 |
GO:0007140 | male meiosis | 4.735765e-3 |
GO:0048663 | neuron fate commitment | 4.830280e-3 |
GO:0021794 | thalamus development | 4.925940e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 4.934542e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 4.958997e-3 |
GO:0010390 | histone monoubiquitination | 5.019754e-3 |
GO:0071882 | activation of phospholipase C activity by adrenergic receptor signaling pathway | 5.052338e-3 |
GO:0071881 | inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway | 5.052338e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 5.052338e-3 |
GO:0016598 | protein arginylation | 5.052338e-3 |
GO:0015790 | UDP-xylose transport | 5.052338e-3 |
GO:0046463 | acylglycerol biosynthetic process | 5.087400e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.110385e-3 |
GO:0060434 | bronchus morphogenesis | 5.148028e-3 |
GO:0042396 | phosphagen biosynthetic process | 5.148028e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 5.148028e-3 |
GO:0060425 | lung morphogenesis | 5.182903e-3 |
GO:0008361 | regulation of cell size | 5.224544e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 5.235902e-3 |
GO:0002904 | positive regulation of B cell apoptosis | 5.369400e-3 |
GO:0048840 | otolith development | 5.443898e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 5.634735e-3 |
GO:0048872 | homeostasis of number of cells | 5.696536e-3 |
GO:0043154 | negative regulation of caspase activity | 5.755752e-3 |
GO:0001710 | mesodermal cell fate commitment | 5.759530e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 5.763104e-3 |
GO:0051882 | mitochondrial depolarization | 5.763104e-3 |
GO:0042443 | phenylethylamine metabolic process | 5.763104e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 5.763104e-3 |
GO:0018125 | peptidyl-cysteine methylation | 5.763104e-3 |
GO:0019896 | axon transport of mitochondrion | 5.763104e-3 |
GO:0016142 | O-glycoside catabolic process | 5.763104e-3 |
GO:0046831 | regulation of RNA export from nucleus | 5.764473e-3 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 5.784812e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 5.937066e-3 |
GO:0045730 | respiratory burst | 6.017309e-3 |
GO:0008156 | negative regulation of DNA replication | 6.070616e-3 |
GO:0019049 | evasion of host defenses by virus | 6.285323e-3 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 6.285323e-3 |
GO:0043306 | positive regulation of mast cell degranulation | 6.348655e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 6.348655e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 6.374209e-3 |
GO:0061156 | pulmonary artery morphogenesis | 6.491478e-3 |
GO:0051096 | positive regulation of helicase activity | 6.491478e-3 |
GO:0034470 | ncRNA processing | 6.509446e-3 |
GO:0042158 | lipoprotein biosynthetic process | 6.630952e-3 |
GO:0045840 | positive regulation of mitosis | 6.852066e-3 |
GO:0043409 | negative regulation of MAPKKK cascade | 6.869908e-3 |
GO:0006783 | heme biosynthetic process | 6.870506e-3 |
GO:0035518 | histone H2A monoubiquitination | 6.877755e-3 |
GO:2000543 | positive regulation of gastrulation | 6.906023e-3 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 6.906023e-3 |
GO:0048341 | paraxial mesoderm formation | 7.029923e-3 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 7.092650e-3 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.092650e-3 |
GO:0001895 | retina homeostasis | 7.092650e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 7.121615e-3 |
GO:0008216 | spermidine metabolic process | 7.121615e-3 |
GO:0019452 | L-cysteine catabolic process to taurine | 7.121615e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 7.255720e-3 |
GO:0051225 | spindle assembly | 7.466419e-3 |
GO:0008053 | mitochondrial fusion | 7.476167e-3 |
GO:0060547 | negative regulation of necrotic cell death | 7.476167e-3 |
GO:0021660 | rhombomere 3 formation | 7.483960e-3 |
GO:0021666 | rhombomere 5 formation | 7.483960e-3 |
GO:0002352 | B cell negative selection | 7.483960e-3 |
GO:0032481 | positive regulation of type I interferon production | 7.499790e-3 |
GO:0032768 | regulation of monooxygenase activity | 7.559948e-3 |
GO:0035087 | siRNA loading onto RISC involved in RNA interference | 7.576461e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 7.603226e-3 |
GO:0050882 | voluntary musculoskeletal movement | 7.603226e-3 |
GO:0031167 | rRNA methylation | 7.687029e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 7.687029e-3 |
GO:0008654 | phospholipid biosynthetic process | 7.744802e-3 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 7.786122e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 7.786861e-3 |
GO:0051129 | negative regulation of cellular component organization | 7.789102e-3 |
GO:0072189 | ureter development | 7.819943e-3 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 7.819943e-3 |
GO:0045919 | positive regulation of cytolysis | 7.843793e-3 |
GO:0009597 | detection of virus | 7.843793e-3 |
GO:0010638 | positive regulation of organelle organization | 7.995188e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 8.146818e-3 |
GO:0046488 | phosphatidylinositol metabolic process | 8.173450e-3 |
GO:0030901 | midbrain development | 8.206040e-3 |
GO:0010639 | negative regulation of organelle organization | 8.235110e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 8.337016e-3 |
GO:0042554 | superoxide anion generation | 8.386001e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 8.386001e-3 |
GO:0010463 | mesenchymal cell proliferation | 8.449068e-3 |
GO:0072593 | reactive oxygen species metabolic process | 8.482412e-3 |
GO:0072197 | ureter morphogenesis | 8.560662e-3 |
GO:0048069 | eye pigmentation | 8.560662e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 8.675692e-3 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 8.698553e-3 |
GO:0060708 | spongiotrophoblast differentiation | 8.698553e-3 |
GO:0048859 | formation of anatomical boundary | 8.698553e-3 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 8.698553e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 8.698553e-3 |
GO:0035116 | embryonic hindlimb morphogenesis | 8.709955e-3 |
GO:0046549 | retinal cone cell development | 8.771625e-3 |
GO:0035110 | leg morphogenesis | 8.771625e-3 |
GO:0006401 | RNA catabolic process | 8.856083e-3 |
GO:0001569 | patterning of blood vessels | 8.954291e-3 |
GO:0006396 | RNA processing | 9.035123e-3 |
GO:0035284 | brain segmentation | 9.043183e-3 |
GO:0002040 | sprouting angiogenesis | 9.044193e-3 |
GO:0015760 | glucose-6-phosphate transport | 9.118418e-3 |
GO:0051147 | regulation of muscle cell differentiation | 9.216799e-3 |
GO:0006598 | polyamine catabolic process | 9.544418e-3 |
GO:0060179 | male mating behavior | 9.625556e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 9.625556e-3 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 9.835512e-3 |
GO:0051053 | negative regulation of DNA metabolic process | 1.000956e-2 |
GO:0046590 | embryonic leg morphogenesis | 1.001728e-2 |
GO:0046479 | glycosphingolipid catabolic process | 1.001728e-2 |
GO:0010564 | regulation of cell cycle process | 1.005010e-2 |
GO:0006338 | chromatin remodeling | 1.005352e-2 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.010590e-2 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.013159e-2 |
GO:0016570 | histone modification | 1.040225e-2 |
GO:0010977 | negative regulation of neuron projection development | 1.043412e-2 |
GO:0044070 | regulation of anion transport | 1.045138e-2 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.057268e-2 |
GO:0051354 | negative regulation of oxidoreductase activity | 1.060896e-2 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.061588e-2 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1.062097e-2 |
GO:0070286 | axonemal dynein complex assembly | 1.062097e-2 |
GO:0061154 | endothelial tube morphogenesis | 1.062097e-2 |
GO:0016476 | regulation of embryonic cell shape | 1.062097e-2 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 1.062097e-2 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 1.062097e-2 |
GO:0043302 | positive regulation of leukocyte degranulation | 1.073599e-2 |
GO:2000682 | positive regulation of rubidium ion transport | 1.078097e-2 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 1.078097e-2 |
GO:0048227 | plasma membrane to endosome transport | 1.078097e-2 |
GO:0019556 | histidine catabolic process to glutamate and formamide | 1.078097e-2 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 1.078097e-2 |
GO:0035826 | rubidium ion transport | 1.078097e-2 |